University of Wolverhampton
Browse
Collection All
bullet
bullet
bullet
bullet
Listed communities
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

Wolverhampton Intellectual Repository and E-Theses > School of Applied Sciences > Research Centre in Applied Sciences  > Applied Microbiology Research Group > Aspirin and alterations in DNA repair proteins in the SW480 colorectal cancer cell line.

Please use this identifier to cite or link to this item: http://hdl.handle.net/2436/117148
    Del.icio.us     LinkedIn     Citeulike     Connotea     Facebook     Stumble it!



Title: Aspirin and alterations in DNA repair proteins in the SW480 colorectal cancer cell line.
Authors: Dibra, H. K.
Brown, J. E.
Hooley, Paul
Nicholl, I. D.
Citation: Oncology reports, 24 (1):37-46
Publisher: Spandios Publications
Journal: Oncology reports
Issue Date: 2010
URI: http://hdl.handle.net/2436/117148
DOI: 10.3892/or_00000826
PubMed ID: 20514442
Abstract: Regular aspirin intake is associated with a reduction in the incidence of colorectal cancer. Aspirin has been shown to be cytotoxic to colorectal cancer cells in vitro. The molecular basis for this cytotoxicity is controversial, with a number of competing hypotheses in circulation. One suggestion is that the protective effect is related to the induction of expression of the DNA mismatch repair (MMR) proteins hMLH1, hMSH2, hMSH6 and hPMS2 in DNA MMR proficient cells. We report that treatment of the DNA MMR competent/p53 mutant colorectal cancer cell line SW480 with 1 mM aspirin for 48 h caused changes in mRNA expression of several key genes involved in DNA damage signalling pathways, including a significant down-regulation in transcription of the genes ATR, BRCA1 and MAPK12. Increases in the transcription of XRCC3 and GADD45alpha genes are also reported. Regulation of these genes could potentially have profound effects on colorectal cancer cells and may play a role in the observed chemo-protective effect of aspirin in vivo. Although a correlation was not seen between transcript and protein levels of ATR, BRCA1 and GADD45alpha, an increase in XRCC3 encoded protein expression upon aspirin treatment in SW480 cells was observed by immunoblotting, immunofluorescence and immunohistochemical analysis. This is the first report of XRCC3 gene transcription and encoded protein expression being susceptible to exposure to the non-steroidal anti-inflammatory drug, aspirin. Furthermore, this study indicates that alterations in gene transcription seen in microarray studies must be verified at the protein level.
Type: Article
Language: en
MeSH: Anti-Inflammatory Agents, Non-Steroidal
Aspirin
Carcinoma
Cell Line, Tumor
Cell Survival
Colorectal Neoplasms
DNA Repair
Dose-Response Relationship, Drug
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Humans
Neoplasm Proteins
Oligonucleotide Array Sequence Analysis
ISSN: 1791-2431
Appears in Collections: Applied Microbiology Research Group
Cancer Research Group

Files in This Item:

There are no files associated with this item.



Related articles on PubMed
bullet
A novel mechanism for aspirin-mediated growth inhibition of human colon cancer cells.
Goel A, Chang DK, Ricciardiello L, Gasche C, Boland CR
2003 Jan
bullet
Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection.
Rüschoff J, Wallinger S, Dietmaier W, Bocker T, Brockhoff G, Hofstädter F, Fishel R
1998 Sep 15
bullet
Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
Sergent C, Franco N, Chapusot C, Lizard-Nacol S, Isambert N, Correia M, Chauffert B
2002 Jun
bullet
bullet
Alterations of DNA mismatch repair proteins and microsatellite instability levels in gastric cancer cell lines.
Yao Y, Tao H, Kim JJ, Burkhead B, Carloni E, Gasbarrini A, Sepulveda AR
2004 Jul
See all 90 articles

All Items in WIRE are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Fairtrade - Guarantees a better deal for Third World Producers

University of Wolverhampton, Wulfruna Street, Wolverhampton, WV1 1LY

Course enquiries: 0800 953 3222, General enquiries: 01902 321000,
Email: enquiries@wlv.ac.uk | Freedom of Information | Disclaimer and copyright | Website feedback | The University as a charity

OR Logo Powered by Open Repository | Cookies